The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

As per The Business Research Company’s Onychomycosis Treatment Global Market Report 2023, the onychomycosis treatment market is expected to show significant growth in the forecast period.

The Onychomycosis treatment market has exhibited robust growth, ascending from $3.39 billion in 2023 to a projected $3.65 billion in 2024, showcasing a substantial Compound Annual Growth Rate (CAGR) of 7.5%. The surge is attributed to the increasing prevalence of fungal infections, an aging population, heightened public awareness, and the rising incidence of Onychomycosis, fueled further by growing disposable incomes.

Anticipating Strong Growth: Projections for the Future

Forecasted Growth in the Next Few Years:

• The Onychomycosis treatment market is poised for robust growth, expected to reach $4.73 billion in 2028.
• The forecasted Compound Annual Growth Rate (CAGR) for this period is 6.7%.

Drivers of Future Growth:

• An aging population and expanding telemedicine services.
• Adoption of combination therapies for enhanced efficacy.
• Increased access to healthcare facilities.
• Changing lifestyles and environmental factors.
• A rising prevalence of diabetes contributing to Onychomycosis cases.

Trends Shaping the Future:

• Dermatological advancements for precision in treatment.
• Innovations in drug delivery methods.
• Personalized treatment plans tailored to individual needs.
• Advances in topical treatments and the advent of digital health solutions.
• Integration of laser therapy for effective Onychomycosis management.

Diabetes Prevalence Driving Onychomycosis Treatment Market Growth

Impact of Diabetes on Onychomycosis:

• The escalating prevalence of diabetes is a significant driver of Onychomycosis treatment market growth.
• Diabetes, a chronic condition, elevates the risk of Onychomycosis and impedes the healing process.

Global Diabetes Statistics:

• In 2021, the US reported over 34.2 million individuals living with diabetes.
• Globally, it is projected that the number of people affected by diabetes will surge by 578 million by 2030.

View More On The Onychomycosis Treatment Market Report 2023 – https://www.thebusinessresearchcompany.com/report/onychomycosis-treatment-global-market-report

Key Players in the Onychomycosis Treatment Market: Innovating for Success

Major Players in the Market:

• Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Viatris Inc., and other industry leaders play a crucial role in steering the growth of the Onychomycosis treatment market.
• Focus on innovative product approvals is key to gaining a competitive edge.

Innovative Product Approval:

• Moberg Pharma AB’s approval for MOB-015 in the European Union is a testament to the importance of new product development.
• MOB-015 demonstrated improved mycological cure and a higher total cure rate, marking a significant advancement in topical terbinafine formulations.

Strategic Acquisitions: A Leap Towards Expansion

Karo Healthcare’s Acquisition of Lamisil:

• In August 2023, Karo Healthcare AB acquired Lamisil from Haleon PLC for approximately $297.86 million.
• The acquisition aims to expand Karo Healthcare’s OTC offering, enhance its foot health portfolio, and increase its geographical presence.

Market Segmentation: Navigating Treatment Dynamics

1) By Type:

• Distal Sublingual Onychomycosis, White Superficial Onychomycosis, Proximal Sublingual Onychomycosis, Candida Onychomycosis, and Other Types offer diverse classifications.

2) By Treatment Type:

• Drugs, Laser Therapy, and Photodynamic Therapy present varied approaches to Onychomycosis treatment.

3) By Age Group:

• Treatment considerations extend across age groups, including 0 to 18 Years, 18 to 39 Years, 40 to 64 Years, and 65 Years and Above.

4) By Distribution Channel:

• Hospital Pharmacies, Retail Pharmacies, and Other Distribution Channels cater to diverse consumer needs.

Request A Sample Of The Global Onychomycosis Treatment Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12941&type=smp

The Onychomycosis Treatment Global Market Report 2023  provides an in-depth analysis on the onychomycosis treatment market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the onychomycosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –

Generic Pharmaceuticals Global Market Report 2023

Biopharmaceuticals Contract Manufacturing Global Market Report 2023

Mid-Size Pharmaceuticals Global Market Report 2023

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model